Concern-Driven Safety Assessment of Nanomaterials - Safety of Nanomaterials along Their Lifecycle - page 374

IHCP2005. REACH and the need for intelligent testing strategies. Institute for Health
and Consumer Protection, European Commission, Joint Research Centre EUR
21554 EN.
Johnston H, Brown D, Kermanizadeh A, Gubbins E, Stone V. (2012). Investigating the rela-
tionship between nanomaterial hazard and physicochemical properties: Informing
the exploitation of nanomaterials within therapeutic and diagnostic applications.
J Controlled Release 164:307-313.
Klein CL, Wiench K, Wiemann M, Ma-Hock L, van Ravenzwaay B, Landsiedel R. (2012).
Hazard identification of inhaled nanomaterials: Making use of short-term inhalation
studies. Arch Toxicol 86:1137-1151.
Kuempel ED, Castranova V, Geraci CL, Schulte PA. (2012). Development of risk-based nano-
material groups for occupational exposure control. J Nanopart Res 14:1029.
Lai ZW, Yan Y, Caruso F, Nice EC. (2012). Emerging techniques in proteomics for probing
nano-bio interactions. ACS Nano 6:10438-48.
Landsiedel R, Fabian E, Ma-Hock L, Wohlleben W, Wiench K, Oesch F, van Ravenzwaay B.
(2012a). Toxico-/biokinetics of nanomaterials. Arch Toxicol 86(7):1021-1060.
Landsiedel R, Ma-Hock L, Haussmann HJ, van Ravenzwaay B, Kayser M, Wiench K. (2012b).
Inhalation studies for the safety assessment of nanomaterials: Status quo and the way
forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4(4):399-413.
Landsiedel R, Ma-Hock L, Kroll A, Hahn D, Schnekenburger J, Wiench K, Wohlleben
W. (2010). Testing metal-oxide nanomaterials for human safety. Adv Mater
22:2601-2627.
Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, Van
Eijkeren JC, Geertsma RE, De Jong WH. (2010). The kinetics of the tissue distribution
of silver nanoparticles of different sizes. Biomat 31:8350-8361.
Linsinger T, Roebben G, Gilliand D, Calzolai L, Rossi F, Gibson P, Klein CH. (2012).
Requirements on measurements for the implementation of the European
Commission definition of the term 'nanomaterial'. JRC publication no JRC73260,
ISBN 978-92-79-25603-5; available at: (http://publications.jrc.ec.europa.eu/repository/
handle/111111111/26399).
Liu J, Legros S, Ma G, Veinot JG, von der Kammer F, Hofmann T. (2012). Influence of surface
functionalization and particle size on the aggregation kinetics of engineered nanopar-
ticles. Chemosphere 87:918-924.
Liu R, Rallo R, George S, Ji Z, Nair S, Nel AE, Cohen Y. (2011). Classification NanoSAR
development for cytotoxicity of metal oxide nanoparticles. Small 7(8):1118-1126.
Lövestam G, Rauscher H, Roebben G, Sokull Klüttgen B, Gibson N, Putaud J-P, StammH.
(2010). Considerations on a definition of nanomaterial for regulatory purposes. JRC
Reference Reports. EUR 24403 EN.
Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, Lynch I, Elia G, Dawson K.
(2011). The evolution of the protein corona around nanoparticles: A test study. ACS
Nano 5:7503-7509.
Ma-Hock L, Burkhardt S, Strauss V, Gamer AO, Wiench K, van Ravenzwaay B, Landsiedel
R. (2009). Development of a short-term inhalation test in the rat using nano titanium
dioxide as a model substance. Inhal Toxicol 21:102-118.
Meng H, Xia T, George S, Nel AE. (2009). A predictive toxicological paradigm for the safety
assessment of nanomaterials. ACS nano 3:1620-1627.
Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V,
Thompson M. (2009). Understanding biophysicochemical interactions at the nano-bio
interface. Nat Mater 8:543-557.
Nel AE, Nasser E, Godwin H, Avery D, Bahadori T, Bergeson L, Beryt E, Bonner JC, Boverhof
D, Carter J, Castranova V, Deshazo JR, Hussain SM, Kane AB, Klaessig F, Kuempel E,
Lafranconi M, Landsiedel R, Malloy T, Miller MB, Morris J, Moss K, Oberdorster G,